Insider Transactions in Q1 2021 at Teva Pharmaceutical Industries LTD (TEVA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2021
|
Mark Sabag EVP, International Markets |
SELL
Open market or private sale
|
Direct |
127,244
-86.07%
|
$1,399,684
$11.22 P/Share
|
|
Mar 05
2021
|
Brendan P. O'Grady EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
11,436
-43.48%
|
$114,360
$10.54 P/Share
|
|
Mar 04
2021
|
Richard Daniell Exec. VP, European Commercial |
SELL
Open market or private sale
|
Direct |
7,513
-27.03%
|
$75,130
$10.58 P/Share
|
|
Mar 04
2021
|
Richard Daniell Exec. VP, European Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
15,920
+36.42%
|
-
|
|
Mar 04
2021
|
Sven Dethlefs EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
6,012
-7.16%
|
$60,120
$10.57 P/Share
|
|
Mar 04
2021
|
Sven Dethlefs EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
13,930
+14.23%
|
-
|
|
Mar 04
2021
|
Eric Drape Executive VP Global Operations |
SELL
Open market or private sale
|
Direct |
6,183
-10.1%
|
$61,830
$10.58 P/Share
|
|
Mar 04
2021
|
Eric Drape Executive VP Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
11,940
+16.32%
|
-
|
|
Mar 04
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
9,515
-11.47%
|
$95,150
$10.57 P/Share
|
|
Mar 04
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
18,905
+18.56%
|
-
|
|
Mar 04
2021
|
Gianfranco Nazzi EVP, International Markets |
SELL
Open market or private sale
|
Direct |
12,935
-100.0%
|
$129,350
$10.58 P/Share
|
|
Mar 04
2021
|
Gianfranco Nazzi EVP, International Markets |
BUY
Grant, award, or other acquisition
|
Direct |
12,935
+50.0%
|
-
|
|
Mar 04
2021
|
Brendan P. O'Grady EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
8,172
-13.32%
|
$81,720
$10.69 P/Share
|
|
Mar 04
2021
|
Brendan P. O'Grady EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
18,905
+35.89%
|
-
|
|
Mar 04
2021
|
Mark Sabag EVP, International Markets |
BUY
Exercise of conversion of derivative security
|
Direct |
15,920
+9.72%
|
-
|
|
Mar 04
2021
|
Kare Schultz President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
59,701
+6.49%
|
-
|
|
Mar 04
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
13,930
-82.41%
|
$139,300
$10.57 P/Share
|
|
Mar 04
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,930
+45.18%
|
-
|
|
Mar 03
2021
|
Richard Daniell Exec. VP, European Commercial |
SELL
Open market or private sale
|
Direct |
993
-7.72%
|
$9,930
$10.88 P/Share
|
|
Mar 03
2021
|
Richard Daniell Exec. VP, European Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
2,101
+14.04%
|
-
|
|
Mar 03
2021
|
Sven Dethlefs EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
606
-0.86%
|
$6,060
$10.86 P/Share
|
|
Mar 03
2021
|
Sven Dethlefs EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,400
+1.94%
|
-
|
|
Mar 03
2021
|
Gianfranco Nazzi EVP, International Markets |
SELL
Open market or private sale
|
Direct |
1,400
-100.0%
|
$14,000
$10.88 P/Share
|
|
Mar 03
2021
|
Gianfranco Nazzi EVP, International Markets |
BUY
Exercise of conversion of derivative security
|
Direct |
1,400
+50.0%
|
-
|
|
Mar 03
2021
|
Brendan P. O'Grady EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
463
-2.89%
|
$4,630
$10.86 P/Share
|
|
Mar 03
2021
|
Brendan P. O'Grady EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,166
+6.78%
|
-
|
|
Mar 02
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
50,000
-43.84%
|
$500,000
$10.82 P/Share
|
|
Mar 02
2021
|
Brendan P. O'Grady EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
15,085
-50.36%
|
$150,850
$10.85 P/Share
|
|
Mar 01
2021
|
Richard Daniell Exec. VP, European Commercial |
SELL
Open market or private sale
|
Direct |
20,598
-65.68%
|
$205,980
$10.85 P/Share
|
|
Mar 01
2021
|
Sven Dethlefs EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
7,486
-9.75%
|
$74,860
$10.83 P/Share
|
|
Mar 01
2021
|
Eric Drape Executive VP Global Operations |
SELL
Open market or private sale
|
Direct |
9,795
-16.58%
|
$97,950
$10.85 P/Share
|
|
Mar 01
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
10,912
-8.73%
|
$109,120
$10.83 P/Share
|
|
Mar 01
2021
|
Gianfranco Nazzi EVP, International Markets |
SELL
Open market or private sale
|
Direct |
75,587
-60.04%
|
$755,870
$10.87 P/Share
|
|
Mar 01
2021
|
Brendan P. O'Grady EVP, North America Commercial |
SELL
Open market or private sale
|
Direct |
73,127
-38.71%
|
$731,270
$10.88 P/Share
|
|
Mar 01
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
18,430
-86.11%
|
$184,300
$10.83 P/Share
|
|
Feb 28
2021
|
Richard Daniell Exec. VP, European Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
20,598
+39.64%
|
-
|
|
Feb 28
2021
|
Sven Dethlefs EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
17,346
+18.43%
|
-
|
|
Feb 28
2021
|
Eric Drape Executive VP Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
19,514
+24.83%
|
-
|
|
Feb 28
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
21,682
+14.78%
|
-
|
|
Feb 28
2021
|
Eliyahu Sharon Kalif EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,430
+50.0%
|
-
|
|
Feb 28
2021
|
Gianfranco Nazzi EVP, International Markets |
BUY
Exercise of conversion of derivative security
|
Direct |
15,177
+16.72%
|
-
|
|
Feb 28
2021
|
Brendan P. O'Grady EVP, North America Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
24,934
+19.48%
|
-
|
|
Feb 28
2021
|
Mark Sabag EVP, International Markets |
BUY
Exercise of conversion of derivative security
|
Direct |
20,598
+13.51%
|
-
|
|
Feb 28
2021
|
Kare Schultz President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
65,047
+7.51%
|
-
|
|
Feb 28
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,430
+46.27%
|
-
|
|
Feb 16
2021
|
Eric Drape Executive VP Global Operations |
SELL
Open market or private sale
|
Direct |
2,079
-4.99%
|
$22,869
$11.13 P/Share
|
|
Feb 16
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
SELL
Open market or private sale
|
Direct |
2,098
-1.99%
|
$23,078
$11.12 P/Share
|
|
Feb 16
2021
|
David Matthew Stark Exec. VP Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,926
-56.9%
|
$43,186
$11.12 P/Share
|
|
Feb 14
2021
|
Eric Drape Executive VP Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
3,926
+8.61%
|
-
|
|
Feb 14
2021
|
Hafrun Fridriksdottir Executive VP, Global R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,355
+4.84%
|
-
|